Life Healthcare reports a revenue increase of 12.7%, fuelled by strong second-half results.
--:--
GUEST - Peter Wharton-Hood, Chief Executive of Life Healthcare Group
KEY HIGHTLIGHTS:
Group revenue up 12.7%, fuelled by strong second-half results
Southern Africa acute PPD growth of 1.6%
Southern Africa acute revenue up 6.5%
Sales of Life Molecular Imaging's Neuraceq® doses up 91.9%
Life Molecular Imaging revenue up 181.3%
Normalised earnings per share (NEPS) up by 48.5% to 132.3 cents
Alliance Medical Group sale concluded
Group distributes cash of R10.6 billion to shareholders in 2024
KEY HIGHTLIGHTS:
Group revenue up 12.7%, fuelled by strong second-half results
Southern Africa acute PPD growth of 1.6%
Southern Africa acute revenue up 6.5%
Sales of Life Molecular Imaging's Neuraceq® doses up 91.9%
Life Molecular Imaging revenue up 181.3%
Normalised earnings per share (NEPS) up by 48.5% to 132.3 cents
Alliance Medical Group sale concluded
Group distributes cash of R10.6 billion to shareholders in 2024